Atlas Trials

CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia

Clinical trial NCT06696846 · RECRUITING

Trial details

NCT number
NCT06696846
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed/Refractory T-cell LymphomaRelapsed/Refractory Acute Myeloid Leukemia
Start date
2024-12-01
Primary completion
2027-11-30
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.